220 related articles for article (PubMed ID: 20040391)
1. Mast cell phenotypes and microvessels in non-small cell lung cancer and its prognostic significance.
Carlini MJ; Dalurzo MC; Lastiri JM; Smith DE; Vasallo BC; Puricelli LI; Lauría de Cidre LS
Hum Pathol; 2010 May; 41(5):697-705. PubMed ID: 20040391
[TBL] [Abstract][Full Text] [Related]
2. The relationship of tryptase- and chymase-positive mast cells to angiogenesis in stage I non-small cell lung cancer.
Ibaraki T; Muramatsu M; Takai S; Jin D; Maruyama H; Orino T; Katsumata T; Miyazaki M
Eur J Cardiothorac Surg; 2005 Oct; 28(4):617-21. PubMed ID: 16125954
[TBL] [Abstract][Full Text] [Related]
3. A lack of correlation between mast cells, angiogenesis, and outcome in non-small cell lung cancer.
Niczyporuk M; Hermanowicz A; Matuszczak E; Dziadziuszko R; Knaś M; Zalewska A; Chyczewski L
Exp Lung Res; 2012 Aug; 38(6):281-5. PubMed ID: 22646306
[TBL] [Abstract][Full Text] [Related]
4. Different growth patterns of non-small cell lung cancer represent distinct biologic subtypes.
Sardari Nia P; Colpaert C; Vermeulen P; Weyler J; Pezzella F; Van Schil P; Van Marck E
Ann Thorac Surg; 2008 Feb; 85(2):395-405. PubMed ID: 18222232
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of mast cell number and microvascular density for the survival of patients with primary colorectal cancer.
Gulubova M; Vlaykova T
J Gastroenterol Hepatol; 2009 Jul; 24(7):1265-75. PubMed ID: 17645466
[TBL] [Abstract][Full Text] [Related]
6. Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer.
Welsh TJ; Green RH; Richardson D; Waller DA; O'Byrne KJ; Bradding P
J Clin Oncol; 2005 Dec; 23(35):8959-67. PubMed ID: 16219934
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.
O'Byrne KJ; Koukourakis MI; Giatromanolaki A; Cox G; Turley H; Steward WP; Gatter K; Harris AL
Br J Cancer; 2000 Apr; 82(8):1427-32. PubMed ID: 10780522
[TBL] [Abstract][Full Text] [Related]
8. Glomeruloid microvascular proliferation is superior to intratumoral microvessel density as a prognostic marker in non-small cell lung cancer.
Tanaka F; Oyanagi H; Takenaka K; Ishikawa S; Yanagihara K; Miyahara R; Kawano Y; Li M; Otake Y; Wada H
Cancer Res; 2003 Oct; 63(20):6791-4. PubMed ID: 14583475
[TBL] [Abstract][Full Text] [Related]
9. Inverse prognostic impact of angiogenic marker expression in tumor cells versus stromal cells in non small cell lung cancer.
Donnem T; Al-Saad S; Al-Shibli K; Delghandi MP; Persson M; Nilsen MN; Busund LT; Bremnes RM
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6649-57. PubMed ID: 18006765
[TBL] [Abstract][Full Text] [Related]
10. Mast cell density, angiogenesis, blood clotting, and prognosis in women with advanced ovarian cancer.
Chan JK; Magistris A; Loizzi V; Lin F; Rutgers J; Osann K; DiSaia PJ; Samoszuk M
Gynecol Oncol; 2005 Oct; 99(1):20-5. PubMed ID: 16055178
[TBL] [Abstract][Full Text] [Related]
11. Tumour angiogenesis and mast cell density in the prognostic assessment of colorectal carcinomas.
Acikalin MF; Oner U; Topçu I; Yaşar B; Kiper H; Colak E
Dig Liver Dis; 2005 Mar; 37(3):162-9. PubMed ID: 15888280
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of intratumoral vessel invasion in completely resected pathologic stage I non-small cell lung cancer.
Miyoshi K; Moriyama S; Kunitomo T; Nawa S
J Thorac Cardiovasc Surg; 2009 Feb; 137(2):429-34. PubMed ID: 19185165
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of microvessel density and mast cell density for the survival of Thai patients with primary colorectal cancer.
Yodavudh S; Tangjitgamol S; Puangsa-art S
J Med Assoc Thai; 2008 May; 91(5):723-32. PubMed ID: 18672639
[TBL] [Abstract][Full Text] [Related]
14. Tumor angiogenesis in predicting the survival of patients with stage I lung cancer.
Medetoglu B; Gunluoglu MZ; Demir A; Melek H; Buyukpinarbasili N; Fener N; Dincer SI
J Thorac Cardiovasc Surg; 2010 Nov; 140(5):996-1000. PubMed ID: 20708755
[TBL] [Abstract][Full Text] [Related]
15. Refractory remodeling of the microenvironment by abnormal type V collagen, apoptosis, and immune response in non-small cell lung cancer.
Souza P; Rizzardi F; Noleto G; Atanazio M; Bianchi O; Parra ER; Teodoro WR; Carrasco S; Velosa AP; Fernezlian S; Ab'saber AM; Antonângelo L; Takagaki T; Schainberg CG; Yoshinari NH; Capelozzi VL
Hum Pathol; 2010 Feb; 41(2):239-48. PubMed ID: 19828174
[TBL] [Abstract][Full Text] [Related]
16. Flt-4-positive endothelial cell density and its clinical significance in non-small cell lung cancer.
Chen F; Takenaka K; Ogawa E; Yanagihara K; Otake Y; Wada H; Tanaka F
Clin Cancer Res; 2004 Dec; 10(24):8548-53. PubMed ID: 15623638
[TBL] [Abstract][Full Text] [Related]
17. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ
Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470
[TBL] [Abstract][Full Text] [Related]
18. Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer.
Harpole DH; Richards WG; Herndon JE; Sugarbaker DJ
Ann Thorac Surg; 1996 May; 61(5):1470-6. PubMed ID: 8633961
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of angiogenesis assessment with anti-factor-VIII and anti-CD31 immunostaining in non-small cell lung cancer.
Giatromanolaki A; Koukourakis MI; Theodossiou D; Barbatis K; O'Byrne K; Harris AL; Gatter KC
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2485-92. PubMed ID: 9815651
[TBL] [Abstract][Full Text] [Related]
20. Urokinase plasminogen activator and plasminogen activator inhibitor type-1 in nonsmall-cell lung cancer: relation to prognosis and angiogenesis.
Offersen BV; Pfeiffer P; Andreasen P; Overgaard J
Lung Cancer; 2007 Apr; 56(1):43-50. PubMed ID: 17207889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
